Family · Pharmaceutical analytical standards
Desipramine
A tricyclic antidepressant, the main active metabolite of imipramine: it potently and fairly selectively blocks the reuptake of noradrenaline. First described in the literature in 1959, it was approved in the United States in 1964 for depression. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Among the tricyclics it has the highest affinity for the noradrenaline transporter and the weakest antihistamine effect: so, instead of causing drowsiness, it can cause insomnia.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
